Preprint Review Version 1 This version is not peer-reviewed

IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications

Version 1 : Received: 5 October 2024 / Approved: 6 October 2024 / Online: 7 October 2024 (07:37:25 CEST)

How to cite: Choate, K. A.; Pratt, E. P.; Jennings, M. J.; Winn, R. J.; Mann, P. B. IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications. Preprints 2024, 2024100393. https://doi.org/10.20944/preprints202410.0393.v1 Choate, K. A.; Pratt, E. P.; Jennings, M. J.; Winn, R. J.; Mann, P. B. IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications. Preprints 2024, 2024100393. https://doi.org/10.20944/preprints202410.0393.v1

Abstract

In 2021, the World Health Organization classified isocitrate dehydrogenase (IDH) mutant gliomas as a distinct subgroup of tumors with genetic changes sufficient to enable a complete diagnosis. Patients with an IDH mutant glioma have improved survival which has been further enhanced by the advent of targeted therapies. IDH enzymes contribute to cellular metabolism, and mutations to specific catalytic residues result in the neomorphic production of D-2-hydroxyglutarate (D-2-HG). The accumulation of D-2-HG results in epigenetic alterations, oncogenesis and impacts the tumor microenvironment via immunological modulations. Here, we summarize the molecular, cellular, and clinical implications of IDH mutations in gliomas as well as current diagnostic techniques.

Keywords

Isocitrate Dehydrogenase; IDH1; IDH2; D-2-Hydroxyglutarate; D-2-HG; Epigenetics; Glioma

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.